UBS Maintains Buy on Moderna, Raises Price Target to $151

MODERNA +7.48%

MODERNA

MRNA

41.11

+7.48%

UBS analyst Eliana Merle maintains Moderna (NASDAQ: MRNA) with a Buy and raises the price target from $143 to $151.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via